.gen Technologies Inc.

And great backstory from xconomy.com in HCV and treatment similarities (including business model parallels) with HIV.  http://www.xconomy.com/san-diego/2009/03/17/using-hiv-as-model-anadys-develops-drug-cocktail-ingredient-for-hepatitis-c/

It’s a hot week for Hepatitis C (HCV) treatment news. This morning local biotech Anadys was cleared by the FDA for more extensive trials of their non-nuc HCV treatment – which in early trials was shown to be extremely effective in reducing virus levels quickly.  http://www.xconomy.com/san-diego/2009/07/30/anadys-cleared-to-start-hepc-trial/